Fibrinogen Concentrate (Human) and Insulin lispro Subcutaneous
Determining the interaction of Fibrinogen Concentrate (Human) and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fibrinogen
Brand name: RiaSTAP
Synonyms: Fibrinogen
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fibrinogen Concentrate (Human)-Insulin NPH
- Fibrinogen Concentrate (Human)-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Fibrinogen Concentrate (Human)-Insulin NPH (Vials)
- Fibrinogen Concentrate (Human)-Insulin NPH and Insulin Regular
- Fibrinogen Concentrate (Human)-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Fibrinogen Concentrate (Human)-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Fibrinogen Intravenous
- Insulin lispro Subcutaneous-Fibryga
- Insulin lispro Subcutaneous-Fidaxomicin
- Insulin lispro Subcutaneous-Filgrastim
- Insulin lispro Subcutaneous-Filgrastim Injection
- Insulin lispro Subcutaneous-Filgrastim, Tbo-filgrastim